Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fez family zinc finger protein 2 (FEZF2) is a zinc finger transcription factor that acts as a master regulator of neocortical projection neuron identity during early corticogenesis, specifying corticospinal motor neurons and other subcerebral projection neurons by activating gene expression programs necessary for glutamatergic identity and axonal patterning. Loss of FEZF2 causes mis-specification of neuronal fates, whereas its ectopic expression can reprogram neurons toward subcerebral identities. FEZF2 functions as a transcriptional repressor, is highly expressed in the developing cerebral cortex, and plays essential roles in neuronal subtype specification, axonal guidance, and nervous system development. It is localized to the nucleus and implicated in both developmental neurobiology and certain neurodevelopmental diseases, including autism spectrum disorder and thymic dysplasia[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fez family zinc finger protein 2 (FEZF2).